In these studies, we evaluated the effect of roflumilast on CFTR activity in vivo to afford additional evidence demonstrating the relevancy of the CFTR pathway in mediating the effect of roflumilast, specifically, and as a treatment approach for COPD, more broadly. The gene discussed is CFTR; the disease is chronic obstructive pulmonary disease.